Table 1.
Demographic data of the eyes included in this study
| Controls | Treated eyes | All | |
|---|---|---|---|
| Gender | |||
| Male | 9 (30.00) | 17 (45.95) | 26 (38.81) |
| Female | 21 (70.00) | 20 (54.05) | 41 (61.19) |
| Diagnosis | |||
| Normal | 17 (56.67) | 0 (0.00) | 17 (25.37) |
| AMD | 8 (26.67) | 14 (37.84) | 22 (32.84) |
| DR | 3 (10.00) | 18 (48.65) | 21 (31.34) |
| Venous occlusion | 0 (0.00) | 3 (8.11) | 3 (4.48) |
| Other | 2 (6.67) | 2 (5.41) | 4 (5.97) |
| Lens status | |||
| Phakic | 20 (66.67) | 21 (56.76) | 41 (61.19) |
| Pseudophakic | 10 (33.33) | 16 (43.24) | 26 (38.81) |
| Age | 70.53 ± 11.60 | 71.78 ± 10.85 | 71.22 ± 11.12 |
| Mean number of injections | 0.00 ± 0.00 | 9.30 ± 6.15 | 5.13 ± 6.50 |
| Total | 30 (100.00%) | 37 (100.00%) | 67 (100.00%) |
AMD age-related macular degeneration, BCVA best-corrected visual acuity in logMAR, DR diabetic retinopathy